• News
    • Events
    • Press Releases
  • Contact Us
Homepage
  • Home
    • About Us
      • Overview
      • Management
      • Board of Directors
      • Scientific Advisory Board
      • Careers
    • Product
      • Overview
      • Rizaport
      • Tadalafil
      • Loxapine
      • Montelukast
      • More Products
    • R&D Services
      • Overview
      • VersaFilm
      • VetaFilm
      • Services
    • Manufacturing Services
      • Overview
      • Manufacturing & Packaging
      • Services
    • Partnering
      • Overview
      • Trade Shows
      • BD Contacts
    • Investors
      • Overview
      • Shareholder Reports
      • Corporate Governance
      • Press Releases
      • Stock Price
      • Presentations
      • Regulatory Filings
      • XBRL Files
      • Analyst Coverage
      • Videos
      • RSS Feeds
      • IR Contact
  • Home
    • About Us
      • Overview
      • Management
      • Board of Directors
      • Scientific Advisory Board
      • Careers
    • Product
      • Overview
      • Rizaport
      • Tadalafil
      • Loxapine
      • Montelukast
      • More Products
    • R&D Services
      • Overview
      • VersaFilm
      • VetaFilm
      • Services
    • Manufacturing Services
      • Overview
      • Manufacturing & Packaging
      • Services
    • Partnering
      • Overview
      • Trade Shows
      • BD Contacts
    • Investors
      • Overview
      • Shareholder Reports
      • Corporate Governance
      • Press Releases
      • Stock Price
      • Presentations
      • Regulatory Filings
      • XBRL Files
      • Analyst Coverage
      • Videos
      • RSS Feeds
      • IR Contact
INTELGENXHome  >  Investors  >  Press Releases
INTELGENXHome  >  Investors  >  Press Releases
Normal
2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
IntelGenx Reports Results for the Nine Months Ended September 30, 2008 November 12, 2008
IntelGenx Corp. set to file NDA for antidepressant October 10, 2008
IntelGenx Welcomes New Chief Financial Officer, Paul Simmons September 5, 2008
IntelGenx Corp. and Cary Pharmaceuticals Inc. Announce Successful End-of-Phase II Meeting with FDA for Development of their Antidepressant CPI-300 July 30, 2008
IntelGenx Technologies Corp. Engages Auctus Capital Partners Inc. To Perform Investor Relations Activities June 3, 2008
IntelGenx Technologies Corp. Approved for trading on the TSX-Venture Exchange May 22, 2008
IntelGenx Corp. Forms Strategic Alliance with Dava Pharmaceuticals to Develop Cardiovascular Product Addressing a U.S. Market of $1.0 Billion April 14, 2008
IntelGenx Corp. and Cary Pharmaceuticals Confirm Agreement to Develop a Novel Antidepressant April 7, 2008
IntelGenx Technologies Corp. announces closing of private placement March 28, 2008
IntelGenx Corp. Forms Strategic Agreement with Azur Pharma to Develop Prenatal Vitamin Supplements Addressing a U.S. Market of $250 million January 7, 2008
  • Home
    • About Us
      • Overview
      • Management
      • Board of Directors
      • Scientific Advisory Board
      • Careers
    • Product
      • Overview
      • Rizaport
      • Tadalafil
      • Loxapine
      • Montelukast
      • More Products
    • R&D Services
      • Overview
      • VersaFilm
      • VetaFilm
      • Services
    • Manufacturing Services
      • Overview
      • Manufacturing & Packaging
      • Services
    • Partnering
      • Overview
      • Trade Shows
      • BD Contacts
    • Investors
      • Overview
      • Shareholder Reports
      • Corporate Governance
      • Press Releases
      • Stock Price
      • Presentations
      • Regulatory Filings
      • XBRL Files
      • Analyst Coverage
      • Videos
      • RSS Feeds
      • IR Contact

Shareholder Tools

Financial Reports E-mail Alerts RSS News Feeds

About us

  • Overview
  • Management
  • Board of Directors
  • Careers

Product

  • Overview
  • Rizaport
  • Tadalafil
  • Loxapine
  • Montelukast
  • More Products

R&D Services

  • Overview
  • VersaFilm
  • Services

Manufacturing Services

  • Overview
  • Film Manufacturing
  • Services

Partnering

  • Overview

Investors

  • Overview
  • Financial Reports
  • Corporate Governance
  • Press Releases
  • Stock Price
  • Presentations
  • Regulatory Filings
  • Analyst Coverage
  • IR Contact

More Links

  • Facebook
  • Twitter
  • Linkedin
  • Contact us
  • Careers
  • Email Signup
  • RSS Feeds
© Copyright 2017. IntelGenx Corp. All Rights Reserved.
  • Terms of Service
  • Privacy
  • Contact Us
Powered By Q4 Inc. 5.15.0.14